Koollawat Chupradit

2 Wanglang Rd
Bangkok, 10700, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 01, 2026

Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME).

Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME).

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 29, 2025

Enhancing macrophage phagocytosis of cancers by disrupting the SIRPα/CD47 signaling axis and targeting MUC1 antigen.

Enhancing macrophage phagocytosis of cancers by disrupting the SIRPα/CD47 signaling axis and targeting MUC1 antigen.

Journal: The FEBS journal

Published: September 30, 2024

Development of 2LTRZFP-expressing induced pluripotent stem cells as a potential anti-HIV-1 gene therapy against viral integration.

Development of 2LTRZFP-expressing induced pluripotent stem cells as a potential anti-HIV-1 gene therapy against viral integration.

Journal: Journal of leukocyte biology

Published: June 28, 2024

Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers.

Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers.

Journal: Cancer immunology, immunotherapy : CII

Published: April 04, 2024

Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication.

Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication.

Journal: International journal of molecular sciences

Published: November 08, 2022

Biological properties of reverse ankyrin engineered for dimer construction to enhance HIV-1 capsid interaction.

Biological properties of reverse ankyrin engineered for dimer construction to enhance HIV-1 capsid interaction.

Journal: Asian Pacific journal of allergy and immunology

Published: May 22, 2022

Specific Interaction of DARPin with HIV-1 CANTD Disturbs the Distribution of Gag, RNA Packaging, and Tetraspanin Remodelling in the Membrane.

Specific Interaction of DARPin with HIV-1 CANTD Disturbs the Distribution of Gag, RNA Packaging, and Tetraspanin Remodelling in the Membrane.

Journal: Viruses

Published: March 06, 2022

A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors.

A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors.

Journal: PloS one

Published: February 28, 2022

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.

Journal: International journal of molecular sciences

Published: January 12, 2022

Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency.

Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency.

Journal: Scientific reports

Published: December 28, 2021

Immunoreactivity of humanized single-chain variable fragment against its functional epitope on domain 1 of CD147.

Immunoreactivity of humanized single-chain variable fragment against its functional epitope on domain 1 of CD147.

Journal: Scientific reports

Published: October 12, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026